Table 1 Septic focus, associated pathogen(s) and risk factors for infection
Patient | Septic focus and associated pathogen(s) | Risk factors for infection |
|---|---|---|
1 | Septic shock (pneumonia, Staphylococcus aureus) | Microscopic polyangiits, cryoglobulinemia, chronic renal disease |
2 | Severe sepsis (soft tissue infection, Streptococcus pyogenes) | None |
3 | Septic shock | Pancytopenia, cryoglobulinemia |
4 | Septic shock (perianal soft tissue infection, Streptococcus group A) | Excision of an anal tag |
5 | Septic shock (pneumonia, Pseudomonas aeruginosa) | UIP, Sjögren's syndrome, alveolitis, immune complex vasculitis |
6 | Septic shock (parastomal abscess, Peptostreptococcus, Candida) with septic or Infliximab-associated cardiomyopathy | Crohn's disease with anal and parastomal fistulas |
7 | Septic shock (pneumonia, Streptococcus pneumoniae) | Post splenectomy |
8 | Septic shock (pneumonia, Escherichia coli) | None |
9 | Septic shock | Crohn's disease, short bowel syndrome |
10 | Severe sepsis (rhabdomyolysis and pneumonia, Adenovirus, Streptococcus pneumoniae, Staphylococcus aureus) | None |
11 | Severe sepsis (pneumonia, H1N1) with VAHS | Type 2 Diabetes, obesity hypoventilation syndrome |
12 | Septic shock (pneumonia, Staphylococcus haemolyticus, Candida krusei) | MDS with pancytopenia |
13 | Severe sepsis (pneumonia, H1N1, Strepococcus mitis, Serratia marcescens) with VAHS | None |
14 | Severe sepsis (pneumonia) | MDS, secondary AML, PBSCTx |
15 | Septic shock, OPSI (sinusitis, Streptococcus pneumoniae) | Post splenectomy |
16 | Septic shock (pneumonia, Staphylococcus aureus) | Cystic fibrosis, re-double-lung transplantation, diabetes, liver cirrhosis |
17 | Septic shock (pneumonia, Streptococcus pneumoniae) | Multiple myeloma, AL amyloidosis (cardiac, renal), autologous SCTx 4Â months ago, |
18 | Septic shock (pneumonia) | Septic granulomatosis |
19 | Septic shock, OPSI (chronic otitis, Streptococcus pneumoniae) | Kidney transplantation, rapidly progressive GN, s/p acute rejection 3Â weeks prior with subsequent rituximab treatment |
20 | Septic shock (colon perforation, Pseudomonas aeruginosa, Acinetobacter baumanii, Klebsiella pneumonia) | Crohn’s disease, cachexia |
21 | Septic shock (pneumonia, Streptococcus pneumonia) | COPD |
22 | Septic shock (acute liver failure due to HSV) | Hysterectomy because of uterine myomas |
23 | Septic shock (MOF due to VZV) | Type 2 Diabetes |